ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
Dow Jones
42,840.26
1.18%
US Dollar vs MXN
20.0813
0.00%
Brent Oil
72.72
0.00%
Bitcoin
97,160.92
-0.05%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Neuralstem Inc (CUR) Cotización

Neuralstem Inc

Neuralstem Inc (CUR)

AGUAS DA CURIA
Consolidated Uranium Inc
1.52
0.00
(0.00%)
Cerrado 21 Diciembre 3:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
Fuera de horario: -
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
1.52
Postura de Compra
1.58
Postura de Venta
1.62
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
14.01M
Precio Anterior
1.52
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
9,217,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-1.14
Beneficio por acción (BPA)
-1.33
turnover
250k
Beneficio neto
-12.3M

Acerca de Neuralstem Inc

Neuralstem Inc is a clinical-stage biopharmaceutical company. The company is engaged in research, development, and commercialization of central nervous system therapies based on its human neuronal stem cells and its stem-cell derived small molecule compounds. Its technology base has produced three p... Neuralstem Inc is a clinical-stage biopharmaceutical company. The company is engaged in research, development, and commercialization of central nervous system therapies based on its human neuronal stem cells and its stem-cell derived small molecule compounds. Its technology base has produced three primary assets: NSI-189 small molecule program, NSI-566 stem cell therapy program and novel and proprietary new chemical entity screening platform. Mostrar más

Sector
Biological Pds,ex Diagnstics
Industria
Biological Pds,ex Diagnstics
Sitio web
www.palisadebio.com.
Sede
Camden, Delaware, USA
Fundado
-

CUR Últimas noticias

Más noticias

NeuroRx Announces Dosing of First Patient with ZYESAMI™ in P2/3 Clinical Study for the Treatment of Moderate and Severe COV...

RADNOR, Pa., March 19, 2021 (GLOBE NEWSWIRE) -- NeuroRx, Inc. announced the first patient in its P2/3 study of inhaled ZYESAMI™ in the treatment of moderate and severe COVID-19 (AVICOVID-2) was...

19 Marzo 2021
GlobeNewswire Inc.

Letter from Seneca Biopharma's Executive Chairman

Letter from Seneca Biopharma's Executive Chairman PR Newswire GERMANTOWN, Md., Sept. 2, 2020 GERMANTOWN, Md., Sept. 2, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a...

02 Septiembre 2020
PR Newswire (US)

Seneca Biopharma Announces the Closing of its $5 Million Registered Direct Offering

Seneca Biopharma Announces the Closing of its $5 Million Registered Direct Offering PR Newswire GERMANTOWN, Md., May 27, 2020 GERMANTOWN, Md., May 27, 2020 /PRNewswire/ -- Seneca Biopharma, Inc...

27 Mayo 2020
PR Newswire (US)

Seneca Biopharma to Begin Trading Under New Ticker Symbol SNCA

Seneca Biopharma to Begin Trading Under New Ticker Symbol SNCA PR Newswire GERMANTOWN, Md., Oct. 31, 2019 GERMANTOWN, Md., Oct. 31, 2019 /PRNewswire/ -- Seneca Biopharma, Inc., (Nasdaq: CUR), a...

31 Octubre 2019
PR Newswire (US)

Seneca Biopharma and QYuns Therapeutics Sign Term Sheet for Global Licensing of Novel Monoclonal Antibodies for Treating Auto...

Seneca Biopharma and QYuns Therapeutics Sign Term Sheet for Global Licensing of Novel Monoclonal Antibodies for Treating Auto-Immune Diseases PR Newswire GERMANTOWN, Md., Oct. 30, 2019...

30 Octubre 2019
PR Newswire (US)

Seneca Biopharma to Present at the 7th China Renaissance Healthcare and Life Sciences Leadership Summit

Seneca Biopharma to Present at the 7th China Renaissance Healthcare and Life Sciences Leadership Summit PR Newswire GERMANTOWN, Md., Oct. 28, 2019 GERMANTOWN, Md., Oct. 28, 2019 /PRNewswire/...

28 Octubre 2019
PR Newswire (US)

Neuralstem Becomes Seneca Biopharma

Neuralstem Becomes Seneca Biopharma PR Newswire GERMANTOWN, Md., Oct. 28, 2019 GERMANTOWN, Md., Oct. 28, 2019 /PRNewswire/ -- Neuralstem, Inc. (NASDAQ:CUR), announces that the company has changed...

28 Octubre 2019
PR Newswire (US)

Neuralstem Announces Adjustment to Inducement Grant Under Nasdaq Listing Rule 5636(c)(4)

Neuralstem Announces Adjustment to Inducement Grant Under Nasdaq Listing Rule 5636(c)(4) PR Newswire GERMANTOWN, Md., Oct. 3, 2019 GERMANTOWN, Md., Oct. 3, 2019 /PRNewswire/ -- Neuralstem, Inc...

03 Octubre 2019
PR Newswire (US)

Neuralstem Announces Last Subject Enrolled in Phase 2 Clinical Trial Evaluating Human Neural Stem Cells in Chronic Stroke Pat...

Neuralstem Announces Last Subject Enrolled in Phase 2 Clinical Trial Evaluating Human Neural Stem Cells in Chronic Stroke Patients PR Newswire GERMANTOWN, Md., Sept. 24, 2019 GERMANTOWN, Md...

24 Septiembre 2019
PR Newswire (US)

Neuralstem Reports Second Quarter 2019 Fiscal Results

Neuralstem Reports Second Quarter 2019 Fiscal Results PR Newswire GERMANTOWN, Md., Aug. 14, 2019 GERMANTOWN, Md., Aug. 14, 2019 /PRNewswire/ -- Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical...

14 Agosto 2019
PR Newswire (US)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

CUR - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Neuralstem?
El precio actual de las acciones de Neuralstem es US$ 1.52
¿Cuántas acciones de Neuralstem están en circulación?
Neuralstem tiene 9,217,000 acciones en circulación
¿Cuál es la capitalización de mercado de Neuralstem?
La capitalización de mercado de Neuralstem es USD 14.01M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Neuralstem?
Neuralstem ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Neuralstem?
El ratio precio/beneficio de Neuralstem es -1.14
¿Cuál es el ratio de efectivo a ventas de Neuralstem?
El ratio de efectivo a ventas de Neuralstem es 56.09
¿Cuál es la moneda de reporte de Neuralstem?
Neuralstem presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Neuralstem?
El último ingresos anual de Neuralstem es USD 250k
¿Cuál es el último beneficio anual de Neuralstem?
El último beneficio anual de Neuralstem es USD -12.3M
¿Cuál es la dirección registrada de Neuralstem?
La dirección registrada de Neuralstem es 2140 S DUPONT HWY, CAMDEN, DELAWARE, 19934
¿Cuál es la dirección del sitio web de Neuralstem?
La dirección del sitio web de Neuralstem es www.palisadebio.com.
¿En qué sector industrial opera Neuralstem?
Neuralstem opera en el sector BIOLOGICAL PDS,EX DIAGNSTICS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MYSZMy Size Inc
US$ 4.2001
(211.12%)
121.03M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
78.06M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
34M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.94k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
121.95M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.33M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
310.19M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
306.25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
293.22M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
281.23M

Discusión

Ver feed completo
santafe2 santafe2 32 segundos hace
Apparently the vast majority would like a swift kick in the teeth. I don't get it but clearly I'm in the minority that actually cares about democracy for everyone in this country. In 30 days the idea of democracy in the US is gone and with it, democracy anywhere it's being challenged.
sortagreen sortagreen 1 minuto hace
Merry Christmas... And all the other holidays too. My dogs are all agnostic.
wadegarret wadegarret 1 minuto hace
GERN- I'm planning on adding 30K shares at $3.50

or less next week in my real portfolio. I would double down in Wadegarret, but IART has great potential as well.
GERN
manibiotech manibiotech 1 minuto hace
That's exactly what I said in Jan how MHRA will work being a govt agency . People were expecting a govt agency to work with Jet packs on overnight (from Dec 31 , 23 to Jan 1 , 24 ) which is absurd/ naive/silly to put it very politely . That's why I always said it was silly to expect approval by Marc
NWBO
iateclube iateclube 2 minutos hace
I no longer view LQMT as any kind of serious investment, and will not until someone in China decides it needs to be a profit center. So, just playing this like the actuarial probability as one part of a larger portfolio. Out of every five holdings, I expect one to fail, two to languish, one to bre
LQMT
HappyAlways HappyAlways 2 minutos hace
Charge extra 100% to all 2nd home buyers. Many countries did that to combat the situation. 
FNMA
surfer44 surfer44 3 minutos hace
Neil Diamond sings "Holly Holy" Live in Concert Hot August Night III 2012 Greek Theatre HD 1080p

https://youtu.be/WOIadTkXLRc
sortagreen sortagreen 3 minutos hace
we're a little fucked.
rogers711 rogers711 4 minutos hace
Or we might hear a bunch of nonsense style="font-size: 1em"for the third month in a row 😂
RDGL
Graniteguy Graniteguy 5 minutos hace
Spot on assessment of the zero credibility skeptics. Those who don't invest spew FUD over and over and over again. It's a broken record of lies.
AVXL
BDEZ BDEZ 5 minutos hace
149 attacks with explosives in Sweden last year?

https://x.com/elonmusk/status/1870647091325759873
surfer44 surfer44 6 minutos hace
Neil Diamond "Brother Love's Traveling Salvation Show" Live at the Greek Theatre 2012 (HAN III )

https://youtu.be/eSfmm2HxxQo
sortagreen sortagreen 7 minutos hace
Thank you... I'm a very Christmasy Jew. 🤗
carlson carlson 7 minutos hace
The old stick in the head trick...
NBRI
StocktonCA StocktonCA 9 minutos hace
This is Eli Lily's OSA drug that just received FDA Approval.


December 20, 2024

Today, the U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity, to be used
GLP
carlson carlson 10 minutos hace
Good luck to all SHAREHOLDERS!!!
NBRI
Lime Time Lime Time 11 minutos hace
CEO can post updates again here. Please let us know if there is anything new. Happy Holidays.
BCAP
janice shell janice shell 12 minutos hace
This is fun! Read the first few replies in the thread:

https://x.com/patriottakes/status/1870590147055751277
jimr1717 jimr1717 12 minutos hace
Noted and Correct
SHMP
droopyeyes droopyeyes 13 minutos hace
U sold already 
Too late for cheapies clown

imo 
BCDS
Top Penny Top Penny 14 minutos hace
Merry Christmas
PSRU
Top Penny Top Penny 15 minutos hace
OK I'm a buyer again until 2025
PSRU
Preciouslife1 Preciouslife1 15 minutos hace
https://www.mlb.com/news/mlb-rumors-trades-and-signings
gitreal gitreal 15 minutos hace
The current version of the NBRI scam will end like the previous versions: with screwed over investors, billions upon billions of diluted shares, and $0.0001.

It is amazing that penny investors will hit themselves in the head with a stick over and over, never believing that it will h
NBRI

Su Consulta Reciente

NASDAQ
CUR
Neuralstem
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados